Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.58 |
| ▸ | EPOR | P19235 | 3/20 | 0.45 |
| ▸ | NPY1R | P25929 | 1/20 | 0.42 |
| ▸ | NPY4R | P50391 | 1/20 | 0.42 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | NMT2 | O60551 | 1/20 | 0.42 |
| ▸ | NMT1 | P30419 | 1/20 | 0.42 |
| ▸ | GNPAT | O15228 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.39 |
| ▸ | CHRNG | P07510 | 1/20 | 0.39 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.39 |
| ▸ | CHRND | Q07001 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25269707 | 1.00 | GLP1R (0.58) | GLP1REPORNPY1RNPY4RSIRT6 | |
| SCHEMBL24668378 | 0.94 | GLP1R (0.57) | GLP1REPORSIRT6SIRT1NMT2 | |
| SCHEMBL29328877 | 0.92 | GLP1R (0.58) | GLP1REPORSIRT6SIRT1NMT2 | |
| SCHEMBL29329023 | 0.90 | GLP1R (0.56) | GLP1REPORNMT2NMT1FOLH1 | |
| SCHEMBL30094802 | 0.86 | GLP1R (0.59) | GLP1RSIRT6SIRT1NMT2NMT1 | |
| SCHEMBL27401840 | 0.86 | GLP1R (0.52) | GLP1REPORSIRT6SIRT1NMT2 | |
| SCHEMBL16328746 | 0.85 | GLP1R (0.51) | GLP1RSIRT6SIRT1NMT2NMT1 | |
| SCHEMBL24038734 | 0.85 | GLP1R (0.51) | GLP1RNPY1RNPY4RSIRT6SIRT1 | |
| SCHEMBL25596471 | 0.85 | GLP1R (0.51) | GLP1RNPY1RNPY4RSIRT6SIRT1 | |
| SCHEMBL24038735 | 0.85 | GLP1R (0.51) | GLP1RNPY1RNPY4RSIRT6SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174480-A1 | FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS | UNIVERSITE DE STRASBOURG (FR) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174480-A1 | FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS | GPR3, GPR174, GPR139 | GLP1R 311/4885EPOR 1243/4885NPY1R 275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.